The FDA created a green list alert to flag imported GLP-1 active ingredients that may have quality concerns, the spokesperson said, but they noted that the list does not create new limits on legal compounding of drugs
Compounding medications is allowed in several circumstances, including: if the patient requires a different dosage form or strength of a medication than what is commercially available, or if a medication is currently on manufacturer shortage
the drug reduces, not eradicates, appetite and other factors may affect hunger levels
According to Woo-Jin Song and colleagues: "Most, if not all effects of GLP-1 and E4 in beta cells appear to require intracellular activation of the adenosine-3-5-cyclic monophosphate (cAMP)- protein kinase A (PKA) signaling pathway by the G-protein coupled receptor of GLP-1, which is highly expressed on pancreatic beta cells
I could think straight, I wasnt searching for words as much, and I could take in more information without getting so neurologically overwhelmed
Diabetes Care 46, 209221